Biological control shows promise for promoting maize growth and inhibiting Fusarium verticillioides in maize crops, suggesting a safer agricultural method.
Maize (Zea mays L.) cultivation is severely affected by Fusarium verticillioides, a highly adaptable systemic pathogen that causes serious yield losses, reduces grain quality, and produces toxic fumonisin, posing significant health risks to humans and livestock. A biological control approach to combating it was investigated. Streptomyces sp. BPTC-684 showed strong inhibitory activity (53.11%) against F. verticillioides BNGO-16, isolated from a diseased tissue sample. Based on physiological and biochemical characteristics, 16S rRNA gene sequencing, average nucleotide identity, and digital DNA–DNA hybridization, strain BPTC-684 is considered a candidate new species belonging to the genus Streptomyces. In silico analysis of Streptomyces sp. BPTC-684 showed that it expresses diverse biosynthetic gene clusters encoding potential bioactive compounds, notably antibiotics (kinamycin, antimycin, fuelimycins A-C, hangtaimycin, and deoxyhangtaimycin) and siderophores (desferrioxamines B and E). In addition, plant growth-promoting behaviors, such as indole-3-acetic acid production; phosphate solubilization; and the production of extracellular lytic enzymes that degrade cellulose, chitin, proteins, amylose, and xylan, were also discovered in Streptomyces sp. BPTC-684. The pot experiments demonstrated that plant height, fresh weight, and dry root weight were increased in strain BPTC-684 by 37.88%, 132.50%, and 223.81%, respectively, compared to F. verticillioides BNGO-16 on the 15th day of infection. These findings suggest that Streptomyces sp. BPTC-684 is a promising biological control agent for inhibiting fungal diseases and promoting maize growth.
No takes yet. Share an insight, caveat, or question.
Van et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: